Q8E657 AF NFT

6,7-dimethyl-8-ribityllumazine synthase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeicmeab2pbegodfez32ypqdsppk6sbsjkttxqwras4rmmppsbkmc6e/metadata.json
IPFS of structure file: 
bafybeibjrhpb5ywffn77hocoe43wxa2qwkptvatilrtohk7rqj76pp6lki/AF-Q8E657-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xf4ED13986579E8e227b3ED6c02276c648754EC27
First NFT owner address (bech32): 
genesis17nk38xr9085wyfana4kqyfmvvjr4fmp80usw7n
Current NFT ID #346783 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
346783
Accession (UniProt):
Q8E657
Name::
6,7-dimethyl-8-ribityllumazine synthase
Experimental Method:
Predicted structure
Sequence source:
STREPTOCOCCUS AGALACTIAE SEROTYPE III (STRAIN NEM316)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q8E657 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q8E657|RISB_STRA3 6,7-dimethyl-8-ribityllumazine synthase OS=Streptococcus agalactiae serotype III (strain NEM316) OX=211110 GN=ribH PE=3 SV=1 MTIIEGQLVANEMKIGIVVSRFNELITSKLLSGAVDGLLRHGVSEEDIDIVWVPGAFEIPYMARKMALYKDYDAIICLGVVIKGSTDHYDYVCNEVTKGIGHLNSQSDIPHIFGVLTTDNIEQAIERAGTKAGNKGYDCALSAIEMVNLDKKLRER